Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Jade Biosciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- −2 vs. Q2 2023
- Shares held
- 28.5M
- −7.64K (0.0%) vs. Q2 2023
- Total value
- $386.3M
- −$102.0M (−20.9%) vs. Q2 2023
- New holders
- 2
- 22 more added
- Sold out
- 4
- 12 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $112.1M | 2.21% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $51.0M | 3.54% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,201,274 | $29.9M | 4.40% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27.7M | 4.29% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,963,479 | $26.6M | 0.15% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,561,696 | $21.2M | 1.24% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $16.4M | 1.09% | +210,009+21.1% | Added |
| Driehaus Capital Management LLC | 1,187,618 | $16.1M | 0.21% | −6,473−0.5% | Reduced |
| Great Point Partners LLC | 1,091,233 | $14.8M | 2.79% | +159,075+17.1% | Added |
| OrbiMed Advisors LLC | 756,930 | $10.3M | 0.24% | 00.0% | Unchanged |
| BlackRock Inc. | 682,781 | $9.27M | 0.00% | +60,134+9.7% | Added |
| OUP Management Co., LLC | 603,762 | $8.19M | 18.43% | 00.0% | Unchanged |
| Vanguard Group Inc | 599,102 | $8.13M | 0.00% | +75,535+14.4% | Added |
| FMR LLC | 529,544 | $7.19M | 0.00% | −198,070−27.2% | Reduced |
| Octagon Capital Advisors LP | 497,370 | $6.75M | 1.19% | −124,342−20.0% | Reduced |
| Geode Capital Management, LLC | 249,808 | $3.39M | 0.00% | +46,750+23.0% | Added |
| Ghost Tree Capital, LLC | 201,197 | $2.73M | 1.32% | 00.0% | Unchanged |
| State Street Corp | 181,504 | $2.46M | 0.00% | −7,370−3.9% | Reduced |
| Northern Trust Corp | 110,443 | $1.50M | 0.00% | +22,446+25.5% | Added |
| Silverarc Capital Management, LLC | 100,000 | $1.36M | 0.51% | +100,000 | New |
| Nantahala Capital Management, LLC | 95,000 | $1.29M | 0.16% | 00.0% | Unchanged |
| Millennium Management LLC | 53,365 | $724.2K | 0.00% | +19,978+59.8% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 50,866 | $690.0K | 0.00% | 00.0% | Unchanged |
| Eversept Partners, LP | 50,242 | $681.8K | 0.08% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 47,936 | $650.5K | 0.53% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 36,310 | $492.7K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 29,542 | $400.9K | 0.00% | +2,869+10.8% | Added |
| Bank of New York Mellon Corp | 27,412 | $372.0K | 0.00% | +180+0.7% | Added |
| Fred Alger Management, LLC | 24,747 | $335.8K | 0.00% | −33,127−57.2% | Reduced |
| Swiss National Bank | 21,201 | $287.7K | 0.00% | +5,000+30.9% | Added |
| Parkwood LLC | 20,653 | $280.0K | 0.05% | −2,179−9.5% | Reduced |
| Dimensional Fund Advisors LP | 20,546 | $278.9K | 0.00% | −4,465−17.9% | Reduced |
| Alps Advisors Inc | 20,395 | $276.8K | 0.00% | +2,075+11.3% | Added |
| Morgan Stanley | 19,053 | $258.6K | 0.00% | −13,973−42.3% | Reduced |
| Squarepoint Ops LLC | 17,644 | $239.4K | 0.00% | +17,644 | New |
| Ensign Peak Advisors, Inc | 15,000 | $203.6K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 13,993 | $189.9K | 0.00% | +1,007+7.8% | Added |
| Alliancebernstein L.P. | 12,450 | $168.9K | 0.00% | +730+6.2% | Added |
| Two Sigma Investments, LP | 11,804 | $160.2K | 0.00% | −18,207−60.7% | Reduced |
| UBS Group AG | 11,214 | $152.2K | 0.00% | +8,215+273.9% | Added |
| California State Teachers Retirement System | 11,012 | $149.4K | 0.00% | +1,116+11.3% | Added |
| Golden State Equity Partners | 10,530 | $142.9K | 0.04% | 00.0% | Unchanged |
| Bank of America Corp | 10,305 | $139.8K | 0.00% | +4,009+63.7% | Added |
| Legal & General Group Plc | 7,692 | $104.4K | 0.00% | +1,918+33.2% | Added |
| JPMorgan Chase & Co | 7,419 | $100.7K | 0.00% | −651−8.1% | Reduced |
| American International Group, Inc. | 5,579 | $75.7K | 0.00% | +735+15.2% | Added |
| MetLife Investment Management | 5,228 | $70.9K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 4,985 | $67.6K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 4,318 | $58.6K | 0.00% | +45+1.1% | Added |
| Barclays PLC | 3,846 | $52.2K | 0.00% | +440+12.9% | Added |
| STRS Ohio | 2,300 | $31.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,254 | $30.6K | 0.00% | −1,946−46.3% | Reduced |
| Amalgamated Bank | 1,535 | $21.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,440 | $19.5K | 0.00% | +532+58.6% | Added |
| Royal Bank of Canada | 1,400 | $19.0K | 0.00% | +520+59.1% | Added |
| Ameritas Investment Partners, Inc. | 772 | $10.5K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 701 | $9.51K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 213 | $2.89K | 0.00% | −3,111−93.6% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −291,938−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −41,803−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −939−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |